• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    United Therapeutics Corporation (UTHR)

    -NasdaqGS
    170.11 Down 2.82(1.63%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:172.93
    Open:173.60
    Bid:160.00 x 200
    Ask:N/A
    1y Target Est:169.93
    Beta:1.4
    Earnings Date:Jul 27 - Jul 31 (Est.)
    Day's Range:168.50 - 174.41
    52wk Range:86.04 - 190.29
    Volume:578,557
    Avg Vol (3m):660,541
    Market Cap:7.86B
    P/E (ttm):47.36
    EPS (ttm):3.59
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for UTHR

    Comparison

    Symbol% ChgMkt Cap
    UTHRDown 1.63%7.86B
    GILDDown 0.84%169.06B
    PFEDown 0.95%205.48B

    Key Statistics

    Forward P/E (1 yr):14.15
    P/S (ttm):6.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :7.38
    Quarterly EPS Est (Jun-15) :2.32
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback